Table 1.
Baseline characteristics of the 106 patients
| 25-OHD (ng/ml) | 13.1 ± 0.6 |
|---|---|
| Demographic characteristics |
|
| Recipient age (years) |
40.2 ± 1.1 |
| Recipient gender (% women) |
31 (29.2) |
| Active vitamin D supplementation before KT |
17 (16.0) |
| Etiology of renal failure (%) |
|
| Diabetes mellitus |
10 (9.4) |
| Glomerulonephritis |
32 (30.2) |
| Hypertension and others |
64 (60.4) |
| Duration of dialysis (months) |
16.8 ± 2.7 |
| History of cardiovascular disease |
8 (7.5) |
| Smoking |
22 (20.8) |
| Body mass index (kg/m2) |
22.8 ± 0.3 |
| Predominant RRT modality before KT (%) |
|
| Hemodialysis |
49 (46.2) |
| Peritoneal dialysis |
22 (20.8) |
| Pre-emptive transplantation |
35 (33.0) |
| Transplant type |
|
| Living-related donor |
76 (71.7) |
| Living-unrelated donor |
29 (27.4) |
| Deceased donor |
1 (0.9) |
| Donor characteristic |
|
| Donor age |
35.1 ± 1.0 |
| Donor gender (% women) |
46 (43.4) |
| ABO mismatch (%) |
15 (14.2) |
| Number of HLA mismatches |
2.8 ± 0.1 |
| Mismatch at A locus (%) |
83 (78.3) |
| Mismatch at B locus (%) |
90 (84.9) |
| Mismatch at DR locus (%) |
87 (82.1) |
| Laboratory test results |
|
| Albumin (g/dl) |
3.8 ± 0.0 |
| Calcium (mg/dl) |
9.1 ± 0.1 |
| Albumin-corrected calcium (mg/dl) |
9.3 ± 0.1 |
| Phosphorus (mg/dl) |
5.8 ± 0.2 |
| Alkaline phosphatase (IU/l) |
68.6 ± 2.6 |
| Parathyroid hormone (intact; pg/ml) |
204.6 ± 19.9 |
| Osteocalcin (ng/ml) |
45.2 ± 4.0 |
| Hemoglobin (g/l) |
9.5 ± 0.2 |
| Biopsy-proven acute rejection episode | 11 (10.4) |
Results are expressed as mean ± SEM or number (%).
KT, kidney transplantation; RRT, renal replacement therapy.